Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
Alida Biosciences
start up
United States
- San Diego
- 13/06/2024
- Series A
- $7,500,000
Alida Biosciences is developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
- Industry Biotechnology Research
- Website https://alidabio.com/
- LinkedIn https://www.linkedin.com/company/alida-biosciences/
Related People
Gudrun StengelFounder
United States -
San Diego, California
Strategic leader and product developer with track record in the commercialization of assays, reagents and integrated platforms for biomedical applications. Specialized in -omics applications.
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)